Context Capital Management »

Karyopharm Therapeutics shares owned by Context Capital Management

Quarter-by-quarter ownership of Karyopharm Therapeutics shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Context Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.9M 8.9k 670.00

Top funds holding Karyopharm Therapeutics